Medicines and Vaccines in Dealing with Covid-19

Xianyi Zheng

2022

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(Wikipedia 2021) has several components, including spike protein and membrane protein, and has several variants. Currently, remdesivir and dexamethasone are two common medicines that are used for treatments of the Covid-19 disease. It has been shown that the recovery time for patients who were treated with these two drugs was much shorter than patients who did not treat with them and the mortality of patients who were treated with them was lower than patients who did not. Also, several vaccines, including vaccines produced by Moderna, vaccines produced by BioNTech/ Pfizer, and vaccines produced by Oxford/ AstraZeneca have shown efficacies in preventing infection of the virus. The efficacies of these three vaccines towards original SARS-CoV-2 were all above 70%, for which vaccine produced by Moderna, vaccine produced by BioNTech/ Pfizer was around 94.5% (Moderna, Inc. 2020) and 95%)(Polack et al. 2020), and that of Oxford/ AstraZeneca was around 70%(NEEDHAM 2020). However, when dealing with SARS-CoV-2 variants, the efficacies of these three vaccines decreased. In conclusion, although different medicines and vaccines have been used to prevent the exacerbation of the Covid-19 pandemic, the emerge of SARS-CoV-2 variants is still a challenge as these variants decrease the efficacies of vaccines and increase the infection rate.

Paper Citation

in Harvard Style

Zheng X. (2022). Medicines and Vaccines in Dealing with Covid-19. In Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB, ISBN 978-989-758-595-1, pages 601-611. DOI: 10.5220/0011248000003443

in Bibtex Style

@conference{icbeb22,
author={Xianyi Zheng},
title={Medicines and Vaccines in Dealing with Covid-19},
booktitle={Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,},
year={2022},
pages={601-611},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011248000003443},
isbn={978-989-758-595-1},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,
TI - Medicines and Vaccines in Dealing with Covid-19
SN - 978-989-758-595-1
AU - Zheng X.
PY - 2022
SP - 601
EP - 611
DO - 10.5220/0011248000003443